183 related articles for article (PubMed ID: 26724872)
21. Advice from professional societies: appropriate use of NSAIDs.
Meara AS; Simon LS
Pain Med; 2013 Dec; 14 Suppl 1():S3-10. PubMed ID: 24373108
[TBL] [Abstract][Full Text] [Related]
22. [Analgesics, NSAIDS, and coxibs in rheumatic pain].
Di Matteo L
Reumatismo; 2006; 58 Spec No.1():84-9. PubMed ID: 23631071
[No Abstract] [Full Text] [Related]
23. [Recommendations for treatment with nonsteroidal anti-inflammatory drugs].
Bolten WW
MMW Fortschr Med; 2005 Aug; 147(31-32):24-7. PubMed ID: 16128192
[TBL] [Abstract][Full Text] [Related]
24. An evidence-based approach to prescribing NSAIDs in musculoskeletal disease: a Canadian consensus. Canadian NSAID Consensus Participants.
Tannenbaum H; Davis P; Russell AS; Atkinson MH; Maksymowych W; Huang SH; Bell M; Hawker GA; Juby A; Vanner S; Sibley J
CMAJ; 1996 Jul; 155(1):77-88. PubMed ID: 8673987
[TBL] [Abstract][Full Text] [Related]
25. Utilization of non-steroidal anti-inflammatory drugs in Quebec: adherence to the Canadian consensus on prescription guidelines.
Moride Y; Ducruet T; Boivin JF; Lavoie F; Rochon S
Can J Clin Pharmacol; 2005; 12(2):e201-11. PubMed ID: 15998959
[TBL] [Abstract][Full Text] [Related]
26. [A choice of a nonsteroidal anti-inflammatory drug with regard to gastrointestinal and cardiovascular' risks].
Pakhomova IG
Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(4):85-89. PubMed ID: 27386591
[TBL] [Abstract][Full Text] [Related]
27. Economic evaluation of the restriction in the use piroxicam in Spain.
Maciá Martínez MÁ
Reumatol Clin; 2015; 11(6):345-52. PubMed ID: 25636384
[TBL] [Abstract][Full Text] [Related]
28. Effectiveness of interventions by community pharmacists to reduce risk of gastrointestinal side effects in nonselective nonsteroidal anti-inflammatory drug users.
Teichert M; Griens F; Buijs E; Wensing M; De Smet PA
Pharmacoepidemiol Drug Saf; 2014 Apr; 23(4):382-9. PubMed ID: 24535837
[TBL] [Abstract][Full Text] [Related]
29. NSAID-induced Gastrointestinal Injury: A Focused Update for Clinicians.
Scheiman JM
J Clin Gastroenterol; 2016 Jan; 50(1):5-10. PubMed ID: 26524151
[TBL] [Abstract][Full Text] [Related]
30. Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications--review and recommendations based on risk assessment.
Chan FK; Graham DY
Aliment Pharmacol Ther; 2004 May; 19(10):1051-61. PubMed ID: 15142194
[TBL] [Abstract][Full Text] [Related]
31. The impact of NSAID treatment on cardiovascular risk - insight from Danish observational data.
Schjerning Olsen AM; Fosbøl EL; Gislason GH
Basic Clin Pharmacol Toxicol; 2014 Aug; 115(2):179-84. PubMed ID: 24690187
[TBL] [Abstract][Full Text] [Related]
32. [Diclofenac: update on tolerableness and spinal anti-inflammatory action].
Sandri A
Minerva Med; 2014 Aug; 105(4):313-8. PubMed ID: 25078485
[TBL] [Abstract][Full Text] [Related]
33. Long-term NSAID use in primary care: changes over a decade and NICE risk factors for gastrointestinal adverse events.
Thompson PW; Tee L; McBride J; Quincey D; Strat Liddiard G
Rheumatology (Oxford); 2005 Oct; 44(10):1308-10. PubMed ID: 15972345
[TBL] [Abstract][Full Text] [Related]
34. Cyclo-oxygenase-2 selective inhibitors and nonsteroidal anti-inflammatory drugs: balancing gastrointestinal and cardiovascular risk.
Moore RA; Derry S; McQuay HJ
BMC Musculoskelet Disord; 2007 Aug; 8():73. PubMed ID: 17683540
[TBL] [Abstract][Full Text] [Related]
35. A very high rate of inappropriate use of gastroprotection for nonsteroidal anti-inflammatory drug therapy in primary care: a cross-sectional study.
Morini S; Zullo A; Oliveti D; Chiriatti A; Marmo R; Chiuri DA; Marotti G; Morelli L; Hassan C
J Clin Gastroenterol; 2011 Oct; 45(9):780-4. PubMed ID: 21918387
[TBL] [Abstract][Full Text] [Related]
36. [NSAID GASTROPATHY IN PATIENTS WITH COMORBID DISEASES].
Morozova TE; Rykova SM; Chukina MA
Eksp Klin Gastroenterol; 2015; (6):64-70. PubMed ID: 26817107
[TBL] [Abstract][Full Text] [Related]
37. Nonsteroidal anti-inflammatory drugs in the treatment of pericarditis.
Schifferdecker B; Spodick DH
Cardiol Rev; 2003; 11(4):211-7. PubMed ID: 12852799
[TBL] [Abstract][Full Text] [Related]
38. Gastroprotective strategies among NSAID users: guidelines for appropriate use in chronic illness.
Targownik LE; Thomson PA
Can Fam Physician; 2006 Sep; 52(9):1100-5. PubMed ID: 17279220
[TBL] [Abstract][Full Text] [Related]
39. Assessment and prevention of gastrointestinal toxicity of non-steroidal anti-inflammatory drugs.
Lane ME; Kim MJ
J Pharm Pharmacol; 2006 Oct; 58(10):1295-304. PubMed ID: 17034651
[TBL] [Abstract][Full Text] [Related]
40. Non-steroidal anti-inflammatory drugs (NSAIDs).
Day RO; Graham GG
BMJ; 2013 Jun; 346():f3195. PubMed ID: 23757736
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
